Article
Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges
2022-08-18
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> COVID-19 oral treatments require initiation within 5 days of symptom onset. Although antigen tests are less sensitive than RT-PCR, rapid results could facilitate entry to treatment. As SARS-CoV-2 variants and host immunity evolve, it is important to characterize the use case for rapid antigen tests for treatment entry. <h4>Methods</h4> We collected anterior nasal swabs for Bin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fef764e1-4a9b-5e48-bf3d-587d28781dd9
- DOI
- 10.1101/2022.08.17.22278913
